Screener
Integra LifeSciences IART Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $214,415 | $235,048 |
| Short-term investments | 59,669 | 28,693 |
| Trade accounts receivable, net of allowances of $7,326 and $7,230 | 267,188 | 278,849 |
| Inventories, net | 492,005 | 492,735 |
| Prepaid expenses | 104,344 | 96,089 |
| Other current assets | 53,861 | 28,130 |
| Total current assets | 1,191,482 | 1,159,544 |
| Property, plant and equipment, net | 446,202 | 444,335 |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's inventories?
- Integra LifeSciences (IART) reported inventories of $492.01M in Q2 2026.
- How has Integra LifeSciences's inventories changed year-over-year?
- Integra LifeSciences's inventories increased by 5.8% year-over-year, from $465.13M to $492.01M.
- What is the long-term trend for Integra LifeSciences's inventories?
- Over 5 years (2020 to 2025), Integra LifeSciences's inventories has grown at a 9.7% compound annual growth rate (CAGR), from $310.12M to $492.74M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Integra LifeSciences's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude